Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.12 USD
Change Today +0.13 / 2.17%
Volume 60.2K
CBRX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for columbia laboratories inc (CBRX)

Year over year, Columbia Laboratories Inc. has been seen their bottom line shrink from $6.7M USD to $3.4M USD despite an increase in revenues from $28.8M USD to $32.5M USD. An increase in the percentage of sales devoted to cost of goods sold from 46.00% to 54.49% was a key component in the falling bottom line in the face of rising revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Restated
Dec 31
2013
Restated
Dec 31
2014
4 Year
Trend
Revenues20.925.728.832.5
Other Revenues5.10.10.1--
TOTAL REVENUES26.125.828.932.5
Cost of Goods Sold11.712.813.317.7
GROSS PROFIT14.413.015.714.8
Selling General & Admin Expenses, Total8.28.67.810.3
R&D Expenses2.80.8--0.7
OTHER OPERATING EXPENSES, TOTAL11.09.37.811.0
OPERATING INCOME3.43.77.93.8
Interest Expense0.0--0.0-0.1
Interest and Investment Income0.10.20.1--
NET INTEREST EXPENSE0.10.20.1-0.1
Currency Exchange Gains (Loss)-0.3-0.10.00.0
Other Non-Operating Income (Expenses)-2.27.00.80.7
EBT, EXCLUDING UNUSUAL ITEMS1.010.88.74.4
Merger & Restructuring Charges-----2.3--
Gain (Loss) on Sale of Investments----0.0--
Gain (Loss) on Sale of Assets19.5------
Other Unusual Items, Total---0.90.3--
Other Unusual Items----0.3--
EBT, INCLUDING UNUSUAL ITEMS20.69.96.74.4
Income Tax Expense0.00.00.01.0
Earnings from Continuing Operations20.59.96.73.4
NET INCOME20.59.96.73.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS20.59.96.73.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS20.59.96.73.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CBRX:US $6.12 USD +0.13

CBRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $47.08 USD +0.30
View Industry Companies
 

Industry Analysis

CBRX

Industry Average

Valuation CBRX Industry Range
Price/Earnings 19.6x
Price/Sales 2.0x
Price/Book 1.6x
Price/Cash Flow 19.0x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COLUMBIA LABORATORIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.